Djibril Wade obtained a Master’s degree in Biology and a university diploma in Biological Retrovirology before being awarded a scholarship from the Belgian Directorate of Cooperation and Development to start a PhD at the University of Antwerp in Belgium. During his PhD research, entitled “Evaluation and Decentralization of CD4 T-cell counting technologies in Senegal,” Djibril assisted with the implementation of a national CD4 Quality Control program and in the decentralization of CD4 monitoring in remote areas. He obtained his PhD in Biomedical Sciences in June 2015 and is the author and co-author of eight papers published in international, peer-reviewed journals. During his post-doctoral research, he was involved in a Clinical Trial assessing the safety and immunogenicity of an Ebola vaccine. His research interests include diagnostic tools and correlates of immune protection from Infectious Diseases, especially HIV, Tuberculosis, Hepatitis and other Emerging and Neglected Tropical pathogens, including Ebola infection. He joined IRESSEF (Institute of Research in Health, Epidemiological Surveillance and Training) in August 2016. Djibril is the Project Manager for iLEAD Senegal.